I
119THCONGRESS
1
STSESSION H. R. 1806
To provide for research and education with respect to triple-negative breast
cancer, and for other purposes.
IN THE HOUSE OF REPRESENTATIVES
MARCH3, 2025
Mr. M
ORELLE(for himself and Mr. BACON) introduced the following bill;
which was referred to the Committee on Energy and Commerce
A BILL
To provide for research and education with respect to triple-
negative breast cancer, and for other purposes.
Be it enacted by the Senate and House of Representa-1
tives of the United States of America in Congress assembled, 2
SECTION 1. SHORT TITLE. 3
This Act may be cited as the ‘‘Triple-Negative Breast 4
Cancer Research and Education Act of 2025’’. 5
SEC. 2. FINDINGS. 6
Congress finds as follows: 7
(1) Breast cancer accounts for 1 in 4 cancer di-8
agnoses among women in this country. 9
VerDate Sep 11 2014 00:50 Mar 18, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H1806.IH H1806
ssavage on LAPJG3WLY3PROD with BILLS 2
•HR 1806 IH
(2) The survival rate for breast cancer has in-1
creased to 90 percent for White women and 78 per-2
cent for African-American women. 3
(3) African-American women are more likely to 4
be diagnosed with larger tumors and more advanced 5
stages of breast cancer despite a lower incidence 6
rate. 7
(4) Early detection for breast cancer increases 8
survival rates for breast cancer, as evidenced by a 5- 9
year relative survival rate of 98 percent for breast 10
cancers that are discovered before the cancer 11
spreads beyond the breast, compared to 23 percent 12
for stage IV breast cancers. 13
(5) Triple-negative breast cancer is a term used 14
to describe breast cancers whose cells do not have 15
estrogen receptors and progesterone receptors, and 16
do not have an excess of the HER2 protein on their 17
sources. 18
(6) It is estimated that between 10 and 20 per-19
cent of female breast cancer patients are diagnosed 20
with triple-negative breast cancer, and studies indi-21
cate the prevalence of triple-negative breast cancer is 22
much higher. 23
VerDate Sep 11 2014 00:50 Mar 18, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H1806.IH H1806
ssavage on LAPJG3WLY3PROD with BILLS 3
•HR 1806 IH
(7) Triple-negative breast cancer most com-1
monly affects African-American women, followed by 2
Hispanic women. 3
(8) Triple-negative breast cancer is a very ag-4
gressive form of cancer which affects women under 5
the age of 50 across all racial and socioeconomic 6
backgrounds. 7
(9) African-American women are 3 times more 8
likely to develop triple-negative breast cancer than 9
White women. 10
(10) Triple-negative breast cancer tends to 11
grow and spread more quickly than most other types 12
of breast cancer. 13
(11) Like other forms of breast cancer, triple- 14
negative breast cancer is treated with surgery, radi-15
ation therapy, or chemotherapy. 16
(12) Early-stage detection of triple-negative 17
breast cancer is the key to survival because the 18
tumor cells lack certain receptors, and neither hor-19
mone therapy nor drugs that target these receptors 20
are effective against these cancers; therefore, early 21
detection and education is vital. 22
(13) Current research and available data do not 23
provide adequate information on— 24
VerDate Sep 11 2014 00:50 Mar 18, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H1806.IH H1806
ssavage on LAPJG3WLY3PROD with BILLS 4
•HR 1806 IH
(A) the rates of prevalence and incidence 1
of triple-negative breast cancer in African- 2
American, Hispanic, and other minority women; 3
(B) the costs associated with treating tri-4
ple-negative breast cancer; and 5
(C) the methods by which triple-negative 6
breast cancer may be prevented or cured in 7
these women. 8
SEC. 3. TRIPLE-NEGATIVE BREAST CANCER. 9
Subpart I of part C of title IV of the Public Health 10
Service Act (42 U.S.C. 285 et seq.) is amended by insert-11
ing after section 417A (42 U.S.C. 285a–7) the following: 12
‘‘SEC. 417B. TRIPLE-NEGATIVE BREAST CANCER. 13
‘‘(a) R
ESEARCH.— 14
‘‘(1) I
N GENERAL.—The Director of the Na-15
tional Institutes of Health (in this section referred 16
to as the ‘Director of NIH’) shall expand, intensify, 17
and coordinate programs for the conduct and sup-18
port of research with respect to triple-negative 19
breast cancer. 20
‘‘(2) A
DMINISTRATION.—The Director of NIH 21
shall carry out this subsection through the appro-22
priate institutes, offices, and centers of the National 23
Institutes of Health, including the Eunice Kennedy 24
Shriver National Institute of Child Health and 25
VerDate Sep 11 2014 00:50 Mar 18, 2025 Jkt 059200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H1806.IH H1806
ssavage on LAPJG3WLY3PROD with BILLS 5
•HR 1806 IH
Human Development, the National Institute of En-1
vironmental Health Sciences, the Office of Research 2
on Women’s Health, and the National Institute on 3
Minority Health and Health Disparities. 4
‘‘(3) C
OORDINATION OF ACTIVITIES .—The Di-5
rector of the Office of Research on Women’s Health 6
shall coordinate activities under this subsection 7
among the institutes, offices, and centers of the Na-8
tional Institutes of Health. 9
‘‘(4) A
UTHORIZATION OF APPROPRIATIONS .— 10
For the purposes of carrying out this subsection, 11
there are authorized to be appropriated such sums 12
as may be necessary for each of the fiscal years 13
2026 through 2031. 14
‘‘(b) E
DUCATION ANDDISSEMINATION OFINFORMA-15
TIONWITHRESPECT TO TRIPLE-NEGATIVEBREAST 16
C
ANCER.— 17
‘‘(1) T
RIPLE-NEGATIVE BREAST CANCER PUB -18
LIC EDUCATION PROGRAM .—The Secretary of 19
Health and Human Services, acting through the Di-20
rector of the Centers for Disease Control and Pre-21
vention, shall develop and disseminate to the public 22
information regarding triple-negative breast cancer, 23
including information on— 24
VerDate Sep 11 2014 00:50 Mar 18, 2025 Jkt 059200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\H1806.IH H1806
ssavage on LAPJG3WLY3PROD with BILLS 6
•HR 1806 IH
‘‘(A) the incidence and prevalence of triple- 1
negative breast cancer among women; 2
‘‘(B) the elevated risk for minority women 3
to develop triple-negative breast cancer; and 4
‘‘(C) the availability, as medically appro-5
priate, of a range of treatment options for 6
symptomatic triple-negative breast cancer. 7
‘‘(2) D
ISSEMINATION OF INFORMATION .—The 8
Secretary may disseminate information under para-9
graph (1) directly or through arrangements with 10
nonprofit organizations, consumer groups, institu-11
tions of higher education, Federal, State, or local 12
agencies, or the media. 13
‘‘(3) A
UTHORIZATION OF APPROPRIATIONS .— 14
For the purpose of carrying out this subsection, 15
there are authorized to be appropriated such sums 16
as may be necessary for each of the fiscal years 17
2026 through 2031. 18
‘‘(c) I
NFORMATION TO HEALTHCAREPROVIDERS 19
W
ITHRESPECT TO TRIPLE-NEGATIVEBREASTCAN-20
CER.— 21
‘‘(1) D
ISSEMINATION OF INFORMATION .—The 22
Secretary of Health and Human Services, acting 23
through the Administrator of the Health Resources 24
and Services Administration, shall develop and dis-25
VerDate Sep 11 2014 00:50 Mar 18, 2025 Jkt 059200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\H1806.IH H1806
ssavage on LAPJG3WLY3PROD with BILLS 7
•HR 1806 IH
seminate to health care providers information on tri-1
ple-negative breast cancer for the purpose of ensur-2
ing that health care providers remain informed 3
about current information on triple-negative breast 4
cancer. Such information shall include the elevated 5
risk for minority women to develop triple-negative 6
breast cancer and the range of available options for 7
the treatment of symptomatic triple-negative breast 8
cancer. 9
‘‘(2) A
UTHORIZATION OF APPROPRIATIONS .— 10
For the purpose of carrying out this subsection, 11
there are authorized to be appropriated such sums 12
as may be necessary for each of the fiscal years 13
2026 through 2031. 14
‘‘(d) D
EFINITION.—In this section, the term ‘minor-15
ity women’ means women who are members of a racial 16
and ethnic minority group, as defined in section 17
1707(g).’’. 18
Æ
VerDate Sep 11 2014 00:50 Mar 18, 2025 Jkt 059200 PO 00000 Frm 00007 Fmt 6652 Sfmt 6301 E:\BILLS\H1806.IH H1806
ssavage on LAPJG3WLY3PROD with BILLS